OGN- Organon & Co.
Organon & Co. (OGN) has 6 insiders with recent SEC Form 4 filings, including 10 buys and 0 sells. OGN is classified in the Pharmaceuticals industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 131.2K | $1.77M | - | |
| Other | 77.9K | $1.05M | - | |
| Other | 65.6K | $882.9K | - | |
| VP | 52.9K | $711.1K | - | |
| Dir | 21.9K | $294.5K | - |
Activity
Buys and sells only
Transactions
10 filings
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 6, 2026 | Holzbaur Lynette | SVP And Corporate Controller | Buy | 26,448 | $13.35 | $353,080.40 | +100.2% | - | - | |
| Nov 12, 2025 | Cox Carrie Smith51 | Executive Chair | Buy | 65,400 | $7.67 | $501,755.34 | +524.5% | +1.3% | - | |
| May 14, 2025 | Cox Carrie Smith51 | Director | Buy | 12,469 | $8.07 | $100,591.16 | New | +12.6% | - | |
| May 7, 2025 | Falcione Aaron | Chief Human Resources Officer | Buy | 5,500 | $8.77 | $48,235.00 | +9.6% | -4.1% | - | |
| May 6, 2025 | Weaver Kirke | Gen. Counsel &Corp. Secy. | Buy | 8,045 | $9.21 | $74,054.23 | +18.1% | +5.9% | +45.6% | |
| May 6, 2025 | Karp Daniel | Executive VP, Corp. Dev. | Buy | 3,500 | $8.24 | $28,828.10 | +8.1% | +5.9% | +45.6% | |
| May 5, 2025 | Walsh Matthew M | Chief Financial Officer | Buy | 11,400 | $8.82 | $100,548.00 | +8.6% | +10.9% | +52.4% | |
| May 5, 2025 | Ali Kevin | Chief Executive Officer | Buy | 34,000 | $8.81 | $299,370.00 | +13.7% | +10.9% | +52.4% | |
| Feb 22, 2024 | Weaver Kirke | Gen. Counsel &Corp. Secy. | Buy | 2,720 | $18.36 | $49,938.93 | +21.8% | +18.4% | -16.5% | |
| Aug 19, 2021 | Francisco Ma. Fatima53 | Director | Buy | 3,000 | $33.79 | $101,370.00 | New | -2.6% | -6.2% |